Although the detailed mechanism of ANP biosynthesis and secretion in the atrium and ventricle has yet to be elucidated, these facts suggest that concentrations of these molecular forms of ANP in the circulation reflects pathophysiological status of cardiomyocytes in patients with heart failure. The gene discussed is NPPA; the disease is heart failure.